The health care sector has been a miserable performer lately -- but these five health trades are bucking the trend.
The contract research organization has been viewed as a logical takeout target of LabCorp. for some time now.
The biotech company's shares have increased about 12% this year, but a number of analysts have downgraded it over the past two months.
Here are Friday's top research calls, including upgrades for J.C. Penney and Square, a downgrade for Lululemon and new coverage on Exxon Mobil.